The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLS.L Regulatory News (SLS)

  • There is currently no data for SLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Standard Life UK Smaller Co's

1 May 2020 16:34

RNS Number : 7202L
Standard Life UK Small.Co's Tst PLC
01 May 2020
 

 

London, UK, 1 May 2020

Edison issues review on Standard Life UK Smaller Companies (SLS)

Standard Life UK Smaller Companies (SLS) is managed by Harry Nimmo at Aberdeen Standard Investments (ASI). He has a long-term record of meaningful outperformance versus the trust's benchmark. The manager has a clearly defined investment process, focusing on quality, growth and momentum, and uses a proprietary screening tool known as the Matrix to sift the investible universe of c 500 companies. Nimmo retains his disciplined approach regardless of the macro background; he says this has served him well across several market cycles. SLS's board has a progressive dividend policy and aims for a maximum 8% discount in normal market conditions.

 

SLS is currently trading at a 2.7% discount to cum-income NAV. This compares with the 6.0%, 5.6%, 5.9% and 4.6% average discounts over the last one, three, five and 10 years respectively. The FY19 annual dividend of 7.70p per share was 10% higher year-on-year, which was the largest increase in the last three years. SLS currently offers a 1.8% dividend yield, although it should be noted that c 60% of the trust's holdings have either suspended or deferred their dividends in recent weeks.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABUGDUGXGDGGB
Date   Source Headline
23rd Feb 202112:13 pmRNSNet Asset Value(s)
22nd Feb 20212:52 pmRNSGearing disclosure
22nd Feb 202112:08 pmRNSNet Asset Value(s)
19th Feb 20213:49 pmRNSNet Asset Value(s)
18th Feb 202111:00 amRNSNet Asset Value(s)
17th Feb 202111:57 amRNSNet Asset Value(s)
16th Feb 202111:26 amRNSNet Asset Value(s)
15th Feb 202112:31 pmRNSGearing Disclosures
15th Feb 202111:22 amRNSNet Asset Value(s)
12th Feb 202111:39 amRNSNet Asset Value(s)
11th Feb 20214:18 pmRNSPortfolio disclosure
11th Feb 202111:37 amRNSNet Asset Value(s)
10th Feb 202110:46 amRNSNet Asset Value(s)
9th Feb 202111:01 amRNSNet Asset Value(s)
8th Feb 202112:52 pmRNSGearing disclosure
8th Feb 202111:19 amRNSNet Asset Value(s)
5th Feb 202111:33 amRNSNet Asset Value(s)
4th Feb 20213:01 pmRNSMonth End Net Asset Value(s)
4th Feb 202111:53 amRNSNet Asset Value(s)
3rd Feb 202111:04 amRNSNet Asset Value(s)
2nd Feb 20211:33 pmRNSNet Asset Value(s)
1st Feb 20212:41 pmRNSGearing disclosure
1st Feb 202110:28 amRNSTotal Voting Rights
29th Jan 202112:32 pmRNSNet Asset Value(s)
28th Jan 202111:40 amRNSNet Asset Value(s)
27th Jan 20215:07 pmRNSTransaction in Own Shares
27th Jan 202111:44 amRNSNet Asset Value(s)
26th Jan 20211:00 pmRNSNet Asset Value(s)
25th Jan 20215:17 pmRNSTransaction in Own Shares
25th Jan 20212:33 pmRNSGearing disclosure
25th Jan 202112:33 pmRNSNet Asset Value(s)
22nd Jan 20215:03 pmRNSTransaction in Own Shares
22nd Jan 202111:42 amRNSNet Asset Value(s)
21st Jan 20215:01 pmRNSTransaction in Own Shares
21st Jan 202111:38 amRNSNet Asset Value(s)
20th Jan 20215:06 pmRNSTransaction in Own Shares
20th Jan 202111:00 amRNSNet Asset Value(s)
19th Jan 20215:00 pmRNSTransaction in Own Shares
19th Jan 202110:51 amRNSNet Asset Value(s)
19th Jan 20219:05 amRNSCompliance with Market Abuse Regulation
18th Jan 202112:57 pmRNSGearing disclosure
18th Jan 202112:38 pmRNSNet Asset Value(s)
15th Jan 202111:46 amRNSNet Asset Value(s)
14th Jan 202111:41 amRNSNet Asset Value(s)
14th Jan 202110:44 amRNSPortfolio disclosure
13th Jan 202111:47 amRNSNet Asset Value(s)
12th Jan 202111:09 amRNSNet Asset Value(s)
11th Jan 202111:50 amRNSGearing disclosure
11th Jan 202111:14 amRNSNet Asset Value(s)
8th Jan 202111:05 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.